Navigation Links
Home Oxygen Patients and Family Members Visit Capitol Hill to Ask Congress to Protect Medicare Home Oxygen Therapy Benefit
Date:7/17/2009

Patient Advocates, Medicare Beneficiaries Visit Capitol Hill to Urge Congress to Pass Medicare Home Oxygen Therapy Act, Oppose Additional Cuts to Oxygen Benefit

WASHINGTON, July 17 /PRNewswire-USNewswire/ -- Asking members of Congress to support patient-focused reform of the Medicare home oxygen therapy benefit, patients and family members with the National Emphysema/COPD Association (NECA), a national advocacy organization representing patients with chronic obstructive pulmonary disease (COPD) and other lung diseases, descended on Capitol Hill this week. Patients urged members of the U.S. House to support and pass the Medicare Home Oxygen Therapy Act of 2009 (H.R. 3220), which was recently introduced.

"Though it is extremely difficult for many users of home oxygen to travel, patients and their families feel strongly enough about home oxygen issues to visit Washington to share their personal stories with their legislators and describe how home oxygen improves quality of life for patients," said Barbara Rogers, President and CEO of NECA. "It is really exciting for us to be here during this transformational time in our nation's healthcare system and we hope our message is heard on Capitol Hill. By meeting with lawmakers and their staff, we want to educate them about home oxygen therapy, explain why there should be no additional cuts to the Medicare home oxygen benefit and ask them to support comprehensive benefit reform."

The Medicare Home Oxygen Therapy Act of 2009 establishes a standard set of patient services, including routine patient evaluations, patient monitoring, equipment training and maintenance and emergency services, all of which play a crucial role in ensuring oxygen users are receiving the medically appropriate level of oxygen that meets their needs and allows them to live safely and comfortably. By ensuring access to these services and important patient safeguards, this legislation recognizes that home oxygen is much more than a piece of oxygen equipment; it is a healthcare service that provides life-supporting oxygen, which enables patients to breathe.

Home oxygen users, family members and advocates oppose additional cuts to the home oxygen benefit, an essential Medicare benefit that serves 1.5 million beneficiaries. In recent years, the benefit has been cut several times, including a cut of more than 25 percent in 2009 alone.

Across the United States, more than 12 million Americans have been diagnosed with Chronic Obstructive Pulmonary Disease (COPD) and other degenerative lung conditions. COPD is currently the fourth leading cause of death in the United States and is on the rise. As a progressive, incurable disease that causes irreversible loss of lung function, COPD can severely confine patients by limiting their daily living activities. Home oxygen therapy is one of the only effective treatments for these patients when properly used.

About NECA

The National Emphysema/COPD Association empowers people with COPD, their families and caregivers to improve the quality of patient care and the quality of their lives. For more information, visit www.necaweb.org.


'/>"/>
SOURCE National Emphysema/COPD Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Congressmen Mike Ross and Kendrick Meek Introduce Bill to Protect Medicare Patients Who Require Medical Oxygen Therapy at Home
2. National Advocacy Organization Representing Home Oxygen Patients Praises Introduction of Medicare Home Oxygen Therapy Act
3. Oxygen Biotherapeutics, Inc. Announces Private Placement Financing Agreement and Offer to Acquire Warrants
4. Oxygen + MRI might help determine cancer therapy success, researchers find
5. Hummingbird Coaching Partners with Leeza's Place to Help Caregivers “Take Your Oxygen First”
6. Long-term study shows low oxygen levels in prostate tumors can predict recurrence
7. Oxygen Biotherapeutics, Inc. Signs Cooperative Research and Development Agreement With Naval Medical Research Center and Walter Reed Army Institute of Research
8. Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel
9. Turtle Island Oxygen Trust Sponsors Free Hyperbaric Treatments
10. G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab
11. Octi-Flo2™ - 8 Patient Portable Oxygen Delivery System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... approved content provider for the National Institute for Health and Care Excellence ... care-related organizations in the National Health Service (NHS) to search, order and purchase ...
(Date:2/23/2017)... ... 2017 , ... Dr. David Mahon leads Siena Dental, a comprehensive dental practice ... a 2017 Top Patient Rated Henderson Dentist by Find Local Doctors earlier ... physicians and dentists who have earned high ratings and superior patient reviews from multiple ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
(Date:2/23/2017)... ... 2017 , ... Healthcare Research & Analytics® (HRA®) in cooperation ... cancer, has produced a seminal study that asked cancer survivors and their caregivers ... a webinar, Defining Compassionate Care Through the Voices of Patients and Advocates that ...
(Date:2/23/2017)... Vienna, VA – , ... ... is coming. It’s the perfect opportunity for the nation to ... out a college basketball bracket – with its favorite fruit ... Association is encouraging apple lovers to join the “Apple Madness” ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Australien, 24. Februar 2017 ... diversifiziertes Unternehmen des Gesundheitsbereiches, ist erfreut, für das ... mit dem entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu ... und Aktualisierung zum Wachstum" finden Sie hier ... Gewinn nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; ...
(Date:2/24/2017)... 23, 2017  The particle counters market is ... from USD 275.9 million in 2016, at a ... report: http://www.reportlinker.com/p04718602-summary/view-report.html The growing ... R&D, and growth in manufacturing industries in emerging ... for particle counters. On the other hand, technical ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... 2016" report to their offering. ... The latest research Autism Spectrum Disorder Drugs ... benchmarks in the global Autism Spectrum Disorder market. The research ... the key drugs marketed for Autism Spectrum Disorder and their clinical ...
Breaking Medicine Technology: